442 related articles for article (PubMed ID: 12099726)
21. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan.
Uda K; Okubo Y; Tsuge M; Tsukahara H; Miyairi I
Vaccine; 2023 Jul; 41(34):4958-4966. PubMed ID: 37400282
[TBL] [Abstract][Full Text] [Related]
22. Varicella zoster virus infection.
Gershon AA; Breuer J; Cohen JI; Cohrs RJ; Gershon MD; Gilden D; Grose C; Hambleton S; Kennedy PG; Oxman MN; Seward JF; Yamanishi K
Nat Rev Dis Primers; 2015 Jul; 1():15016. PubMed ID: 27188665
[TBL] [Abstract][Full Text] [Related]
23. Decline in Severe Varicella Disease During the United States Varicella Vaccination Program: Hospitalizations and Deaths, 1990-2019.
Marin M; Lopez AS; Melgar M; Dooling K; Curns AT; Leung J
J Infect Dis; 2022 Oct; 226(Suppl 4):S407-S415. PubMed ID: 36265852
[TBL] [Abstract][Full Text] [Related]
24. Impact of varicella vaccine on varicella-zoster virus dynamics.
Schmid DS; Jumaan AO
Clin Microbiol Rev; 2010 Jan; 23(1):202-17. PubMed ID: 20065330
[TBL] [Abstract][Full Text] [Related]
25. Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.
Hussey H; Abdullahi L; Collins J; Muloiwa R; Hussey G; Kagina B
BMC Infect Dis; 2017 Nov; 17(1):717. PubMed ID: 29137604
[TBL] [Abstract][Full Text] [Related]
26. Disseminated vaccine-induced varicella infection in a kidney transplant recipient.
Berman MA; Rupp RE
Am J Transplant; 2023 Nov; 23(11):1806-1810. PubMed ID: 37286085
[TBL] [Abstract][Full Text] [Related]
27. Serious neurological adverse events in immunocompetent children and adolescents caused by viral reactivation in the years following varicella vaccination.
Ramachandran P; Grose C
Rev Med Virol; 2024 May; 34(3):e2538. PubMed ID: 38658176
[TBL] [Abstract][Full Text] [Related]
28. Varicella Zoster vaccination in hemodialysis patients: The state of the art.
Gobbi L; Martino FK; Sgrò E; Nalesso F; Calo' LA
Hum Vaccin Immunother; 2023 Dec; 19(3):2286689. PubMed ID: 38010087
[TBL] [Abstract][Full Text] [Related]
29. Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review.
Leung J; Broder KR; Marin M
Expert Rev Vaccines; 2017 Apr; 16(4):391-400. PubMed ID: 28276305
[TBL] [Abstract][Full Text] [Related]
30. The Epidemiology of Chickenpox in England, 2016-2022: An Observational Study Using General Practitioner Consultations.
Bardsley M; Loveridge P; Bednarska NG; Smith S; Morbey RA; Amirthalingam G; Elson WH; Bates C; de Lusignan S; Todkill D; Elliot AJ
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005841
[TBL] [Abstract][Full Text] [Related]
31. Rational Design of a Skin- and Neuro-Attenuated Live Varicella Vaccine: A Review and Future Perspectives.
Wang W; Pan D; Cheng T; Zhu H
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632591
[TBL] [Abstract][Full Text] [Related]
32. Varicella vaccine strain infection in a non-immunocompromised patient. A case report and review of literature.
Swed-Tobia R; Kassis I; Hanna S; Szwarcwort-Cohen M; Dovrat S; Dabaja-Younis H
Hum Vaccin Immunother; 2021 Apr; 17(4):1129-1131. PubMed ID: 32946310
[TBL] [Abstract][Full Text] [Related]
33. Implementation of Hospital Policy for Healthcare Workers and Patients Exposed to Varicella-Zoster Virus.
Kim SH; Park SH; Choi SM; Lee DG
J Korean Med Sci; 2018 Sep; 33(36):e252. PubMed ID: 30181734
[TBL] [Abstract][Full Text] [Related]
34. Management of chickenpox in pregnant women: an Italian perspective.
Parente S; Moriello NS; Maraolo AE; Tosone G
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1603-1609. PubMed ID: 29802481
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.
Rafferty E; McDonald W; Qian W; Osgood ND; Doroshenko A
PeerJ; 2018; 6():e5012. PubMed ID: 29942688
[TBL] [Abstract][Full Text] [Related]
36. Varicella Vaccine Meningitis as a Complication of Herpes Zoster in Twice-Immunized Immunocompetent Adolescents.
Ramachandran V; Elliott SC; Rogers KL; Cohrs RJ; Weinberger M; Jackson W; Carpenter JE; Grose C; Bonthius DJ
J Child Neurol; 2020 Nov; 35(13):889-895. PubMed ID: 32677551
[TBL] [Abstract][Full Text] [Related]
37. Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006-2022.
Moek F; Siedler A
BMC Public Health; 2023 Nov; 23(1):2191. PubMed ID: 37936109
[TBL] [Abstract][Full Text] [Related]
38. Herpes Zoster Recurrence: A Narrative Review of the Literature.
Parikh R; Spence O; Giannelos N; Kaan I
Dermatol Ther (Heidelb); 2024 Mar; 14(3):569-592. PubMed ID: 38416279
[TBL] [Abstract][Full Text] [Related]
39. Zeroing in on zoster: A tale of many disorders produced by one virus.
Galetta KM; Gilden D
J Neurol Sci; 2015 Nov; 358(1-2):38-45. PubMed ID: 26454371
[TBL] [Abstract][Full Text] [Related]
40. Varicella vaccination in Europe - taking the practical approach.
Bonanni P; Breuer J; Gershon A; Gershon M; Hryniewicz W; Papaevangelou V; Rentier B; Rümke H; Sadzot-Delvaux C; Senterre J; Weil-Olivier C; Wutzler P
BMC Med; 2009 May; 7():26. PubMed ID: 19476611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
